The total return over the past 12 months is -86.98% vs. +16.94% for the S&P 500. So far it's up -75.82% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (86.92%) | (94.15%) | (93.52%) | N/A | N/A | N/A |
| Total Return CAGR | (86.98%) | (94.16%) | (93.52%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Revelation Biosciences, Inc. (REVB)
| Year | Start price | End price | REVB Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $3.20 | $0.78 | (75.82%) | +14.51% | (90.33%) |
| 2025 | $88.52 | $3.20 | (96.38%) | +17.72% | (114.10%) |
| 2024 | $2,884.04 | $88.52 | (96.93%) | +24.89% | (121.82%) |
| 2023 | $38,324.12 | $2,884.04 | (92.47%) | +26.19% | (118.66%) |
| 2022 | $685,440.00 | $38,324.12 | (94.41%) | (18.17%) | (76.24%) |
| 2021 | $675,360.00 | $685,440.00 | +1.49% | +28.74% | (27.25%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
